We are pleased to announce that startups can now apply for EIT Health Accelerator 2017 programs until 31 March 2017. Start-ups can get funding, expertise and access to Europe’s biggest health care initiative EIT Heath. It gathers 140 partners from industry, academia and public stakeholders from 16 countries. What kind of programs do we...
Please enter a searchword.
Founded in Freising (near Munich), co-located in Boston (USA), NASDAQ-listed Pieris joins forces in immuno-oncology drug development with Servier Pharma (France).
On November 29 and 30, 230 experts from all over Europe participated in the 6th Munich Biomarker Conference in Munich. The international conference on personalized medicine was organized by BioM, the network agency of Bavaria’s biotechnology industry. Interdisciplinary exchange and dialogue between researchers, physicians, and industry had been...
Immuno-oncology startup iOmx Therapeutics has raised 40 million Euro in its first round of financing.
"We are delighted to collaborate with bluebird bio, a leader in the field of cell and gene therapy, including cancer immunotherapy," said Dolores J. Schendel.
The Munich-based firm also starts to gain a foothold in the American market by setting up a new company in the US (Boston).
Munich Biotech Cluster and lessons learned in 20 years of support for entrepreneurship in biopharma.